Attached files

file filename
8-K - 8-K - Sabra Health Care REIT, Inc.sbra8-k2013q3.htm
EX-99.1 - Q3 2013 EARNINGS RELEASE - Sabra Health Care REIT, Inc.sbraex9912013q3.htm


Exhibit 99.2
Supplemental Information
September 30, 2013
(Unaudited)









Disclaimer
Certain statements in this supplement contain “forward-looking” information as that term is defined by the Private Securities Litigation Reform Act of 1995. Any statements that do not relate to historical or current facts or matters are forward-looking statements. Examples of forward-looking statements include all statements regarding our expected future financial position, results of operations, cash flows, liquidity, business strategy, growth opportunities, potential acquisitions, and plans and objectives for future operations. You can identify some of the forward-looking statements by the use of forward-looking words such as “anticipate,” “believe,” “plan,” “estimate,” “expect,” “intend,” “should,” “may” and other similar expressions, although not all forward-looking statements contain these identifying words.
Our actual results may differ materially from those projected or contemplated by our forward-looking statements as a result of various factors, including the following: our dependence on Genesis HealthCare LLC (“Genesis”), the parent company of Sun Healthcare Group, Inc., until we are able to further diversify our portfolio; our dependence on the operating success of our tenants; changes in general economic conditions and volatility in financial and credit markets; the dependence of our tenants on reimbursement from governmental and other third-party payors; the significant amount of and our ability to service our indebtedness; covenants in our debt agreements that may restrict our ability to make acquisitions, incur additional indebtedness and refinance indebtedness on favorable terms; increases in market interest rates; our ability to raise capital through equity financings; the relatively illiquid nature of real estate investments; competitive conditions in our industry; the loss of key management personnel or other employees; the impact of litigation and rising insurance costs on the business of our tenants; uninsured or underinsured losses affecting our properties and the possibility of environmental compliance costs and liabilities; our ability to maintain our status as a REIT; compliance with REIT requirements and certain tax matters related to our status as a REIT; and other factors discussed from time to time in our news releases, public statements and/or filings with the Securities and Exchange Commission (the “SEC”), especially the “Risk Factors” sections of our Annual and Quarterly Reports on Forms 10-K and 10-Q. We do not intend, and we undertake no obligation, to update any forward-looking information to reflect events or circumstances after the date of this supplement or to reflect the occurrence of unanticipated events, unless required by law to do so.
Note Regarding Non-GAAP Financial Measures
This supplement includes the following financial measures defined as non-GAAP financial measures by the SEC: EBITDA, Adjusted EBITDA, funds from operations (“FFO”), Normalized FFO, Adjusted FFO (“AFFO”), Normalized AFFO, FFO per diluted common share, Normalized FFO per diluted common share, AFFO per diluted common share and Normalized AFFO per diluted common share. These measures may be different than non-GAAP financial measures used by other companies, and the presentation of these measures is not intended to be considered in isolation or as a substitute for financial information prepared and presented in accordance with U.S. generally accepted accounting principles. An explanation of these non-GAAP financial measures is included under “Reporting Definitions” in this supplement and reconciliations of these non-GAAP financial measures to the GAAP financial measures we consider most comparable are included under “Reconciliations of EBITDA, Adjusted EBITDA, Funds from Operations (FFO), Normalized FFO, Adjusted Funds from Operations (AFFO) and Normalized AFFO” in this supplement.
Tenant Information
This supplement includes information regarding each of our tenants that lease properties from us. The information related to these tenants that is provided in this supplement has been provided by the tenants. We have not independently verified this information. We have no reason to believe that such information is inaccurate in any material respect. We are providing this data for informational purposes only.


 




Table of Contents

 
 
 
 
 
 
2013 Outlook
 
 
 
 
 
 
 
 
Reconciliations of EBITDA, Adjusted EBITDA, Funds from Operations (FFO), Normalized FFO, Adjusted Funds from Operations (AFFO) and Normalized AFFO
 
 
 
 
 
 
 
 
Portfolio Summary - All Investments
 
 
Portfolio Summary - Same Store
 
 
 
 
Real Estate Portfolio Geographic Concentrations
 
 
 
 
 
Distribution of Licensed Beds/Units
 
 
 
 
Rental Income - Three Months Ended September 30, 2013
 
 
Rental Income - Nine Months Ended September 30, 2013
 
 
 
 
 
 
Recent Investment Activity
 
 
 
 
 
 
 
 
 
 






Company Information
Board of Directors
 
 
 
 
 
Richard K. Matros
Chairman of the Board, President and
Chief Executive Officer
Sabra Health Care REIT, Inc.
  
Michael J. Foster
Managing Director
RFE Management Corp.
 
 
Milton J. Walters
President
Tri-River Capital
  
Robert A. Ettl
Chief Operating Officer
Harvard Management Company
 
 
Craig A. Barbarosh
Partner
Katten Muchin Rosenman LLP
  
 
Senior Management
 
 
 
 
 
Richard K. Matros
Chairman of the Board, President and
Chief Executive Officer
  
Harold W. Andrews, Jr.
Executive Vice President,
Chief Financial Officer and Secretary
 
 
Talya Nevo-Hacohen
Executive Vice President,
Chief Investment Officer and Treasurer
  
 
Other Information
 
 
 
 
 
Corporate Headquarters
18500 Von Karman Avenue, Suite 550
Irvine, CA 92612
  
Transfer Agent
American Stock Transfer and Trust Company
6201 15th Avenue
Brooklyn, NY 11219
www.sabrahealth.com
The information in this supplemental information package should be read in conjunction with the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other information filed with the SEC. The Reporting Definitions and Reconciliations of Non-GAAP Measures are an integral part of the information presented herein.
On Sabra's website, www.sabrahealth.com, you can access, free of charge, Sabra’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Sections 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, as soon as reasonably practicable after such material is filed with, or furnished to, the SEC. The information contained on Sabra’s website is not incorporated by reference into, and should not be considered a part of, this supplemental information package. All material filed with the SEC can also be accessed through their website, www.sec.gov.
For more information, contact Harold W. Andrews, Jr., Executive Vice President, Chief Financial Officer and Secretary at
(949) 679-0243.

 

See reporting definitions.
1
    



SABRA HEALTH CARE REIT, INC.
COMPANY FACT SHEET
Company Profile
Sabra Health Care REIT, Inc., a Maryland corporation (“Sabra,” the “Company” or “we”), operates as a self-administered, self-managed real estate investment trust (“REIT”) that, through its subsidiaries, owns and invests in real estate serving the healthcare industry. Sabra primarily generates revenues by leasing properties to tenants and operators throughout the United States.
As of September 30, 2013, Sabra’s portfolio included 120 real estate properties held for investment and leased to operators/tenants under triple-net lease agreements (consisting of (i) 96 skilled nursing/post-acute facilities, (ii) 23 senior housing facilities, and (iii) one acute care hospital), six debt investments (consisting of (i) two mortgage loans, (ii) one mezzanine loan, (iii) two pre-development loans, and (iv) one construction mortgage loan) and two preferred equity investments. As of September 30, 2013, Sabra’s real estate properties were located in 27 states and included 12,414 licensed beds.
Objectives and Strategies
Sabra expects to continue to grow its portfolio primarily through the acquisition of senior housing and memory care facilities and with a secondary focus on acquiring skilled nursing facilities. We have and will continue to opportunistically acquire other types of healthcare real estate (including acute care hospitals) and originate financing secured directly or indirectly by healthcare facilities. As Sabra acquires additional properties and expands its portfolio, Sabra expects to further diversify by tenant, asset class and geography within the healthcare sector. Sabra employs a disciplined, opportunistic approach in its healthcare real estate investment strategy by investing in assets that provide attractive opportunities for dividend growth and appreciation of asset values, while maintaining balance sheet strength and liquidity, thereby creating long-term stockholder value.



Market Facts
 
As of September 30, 2013
Stock Information (as of September 30, 2013)
 
Investments
 
Closing Price (common stock):
$23.01
Equity Investments
 
52-Week range (common stock):
$19.89 - $32.40
Skilled Nursing/Post-Acute
96

Market Capitalization:
$0.9 billion
Senior Housing
23

Enterprise Value:
$1.5 billion
Acute Care Hospital
1

Outstanding Shares (common stock):
37.3 million
 
120

Ticker symbols:
 
Debt Investments (1)
6

Common Stock
SBRA
Preferred Equity Investments (2)
2

Preferred Stock
SBRAP
Total Investments
128
Stock Exchange:
NASDAQ
 
 
Credit Ratings
 
Bed/Unit Count
 
Moody's:
 
Skilled Nursing/Post-Acute
10,826

  Senior Notes Rating
B1 (stable)
Senior Housing
1,518

  Preferred Equity Rating
B3
Acute Care Hospital
70

S&P:
 
Total Beds/Units
12,414

Corporate Rating
B+ (stable)
 
 
Senior Notes Rating
BB-
 
 
Preferred Equity Rating
CCC+
 
 
 
 
 





(1) As of September 30, 2013, our Debt Investments related to investments secured directly or indirectly by 13 skilled nursing facilities and a memory care facility with a total of 1,862 beds/units, two assisted living facility developments, and one acute care hospital development.
(2) As of September 30, 2013, our Preferred Equity Investments related to investments in entities owning a skilled nursing facility and an assisted living facility with a total of 193 beds/units.

See reporting definitions.
2
    



SABRA HEALTH CARE REIT, INC.
FINANCIAL HIGHLIGHTS
(dollars in thousands, except per share data)
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2013
 
2012
 
2013
 
2012
Revenues
$
32,926

 
$
26,038

 
$
97,223

 
$
74,882

EBITDA
$
29,818

 
$
21,807

 
$
75,326

 
$
62,591

Adjusted EBITDA
$
29,869

 
$
22,260

 
$
86,027

 
$
63,294

Net income attributable to common stockholders
$
9,242

 
$
5,226

 
$
15,310

 
$
15,554

FFO
$
17,500

 
$
12,722

 
$
40,036

 
$
37,910

Normalized FFO
$
17,851

 
$
13,175

 
$
50,907

 
$
38,613

AFFO
$
16,261

 
$
14,868

 
$
38,464

 
$
44,528

Normalized AFFO
$
16,261

 
$
14,868

 
$
48,476

 
$
44,528

Per common share data:
 
 
 
 
 
 
 
Diluted EPS
$
0.24

 
$
0.14

 
$
0.41

 
$
0.42

Diluted FFO
$
0.46

 
$
0.34

 
$
1.06

 
$
1.02

Diluted Normalized FFO
$
0.47

 
$
0.35

 
$
1.35

 
$
1.04

Diluted AFFO
$
0.43

 
$
0.39

 
$
1.01

 
$
1.18

Diluted Normalized AFFO
$
0.43

 
$
0.39

 
$
1.27

 
$
1.18

Weighted-average number of common shares outstanding, diluted:
 
 
  
 
 
 
 
EPS, FFO and Normalized FFO
37,828,573

 
37,465,114

 
37,777,458

 
37,276,013

AFFO and Normalized AFFO
38,065,299

 
37,748,716

 
38,067,386

 
37,660,657

Net cash flow from operations
$
26,225

 
$
23,815

 
$
49,211

 
$
47,902

 
 
 
 
 
 
 
 
 
September 30, 2013
 
December 31, 2012
 
 
 
 
Real Estate Portfolio
 
 
 
 
 
 
 
Total Equity Investments (#)
120

 
119

 
 
 
 
Total Equity Investments, gross ($)
$
962,809

 
$
956,360

 
 
 
 
Total Licensed Beds/Units
12,414

 
12,382

 
 
 
 
Weighted Average Remaining Lease Term (in months)
125

 
132

 
 
 
 
Total Debt Investments (#)
6

 
2

 
 
 
 
Total Debt Investments, gross ($) (1)
$
39,066

 
$
12,022

 
 
 
 
Total Preferred Equity Investments (#)
2

 

 
 
 
 
Total Preferred Equity Investments, gross ($)
$
7,090

 
$

 
 
 
 
 
 
 
 
 
 
 
Three Months Ended September 30, 2013
 
Twelve Months Ended September 30, 2013
 
 
 
 
EBITDARM Coverage (2)
1.75x

 
1.75x

 
 
 
 
EBITDAR Coverage (2)
1.33x

 
1.32x

 
 
 
 
 
 
 
 
 
 
 
 
 
September 30, 2013
 
December 31, 2012
 
 
 
 
Debt
 
 
 
 
 
 
 
Book Value
 
 
 
 
 
 
 
Fixed Rate Debt
$
499,785

 
$
425,039

 
 
 
 
Variable Rate Debt
56,994

 
150,449

 
 
 
 
Total Debt
$
556,779

 
$
575,488

 
 
 
 
Weighted Average Effective Rate
 
 
 
 
 
 
 
Fixed Rate Debt
6.16
%
 
7.01
%
 
 
 
 
Variable Rate Debt
5.00
%
 
4.21
%
 
 
 
 
Total Debt
6.04
%
 
6.28
%
 
 
 
 
 
 
 
 
 
 
 
 
% of Total
 
 
 
 
 
 
 
Fixed Rate Debt
89.8
%
 
73.9
%
 
 
 
 
Variable Rate Debt
10.2
%
 
26.1
%
 
 
 
 
Total Debt
100.0
%
 
100.0
%
 
 
 
 
 
 
 
 
 
 
 
 
Availability Under Credit Facility:
$
286.477

 
$
109,130

 
 
 
 
Available Liquidity (Unrestricted Cash and Availability Under Credit Facility)
$
383,118

 
$
126,231

 
 
 
 
 

(1) Total Debt Investments, gross consists of principal of $38.6 million plus capitalized origination fees of $0.5 million.
(2) EBITDARM and EBITDAR and related coverages for facilities with new tenants/operators are only included in periods subsequent to our acquisition of the facilities and exclude the impact of strategic disposition candidates and non-stabilized properties. All facility financial performance data are presented one quarter in arrears.


See reporting definitions.
3
    



SABRA HEALTH CARE REIT, INC.
2013 OUTLOOK

For fiscal 2013 the Company expects FFO to range between $1.55 and $1.58 per diluted common share and Normalized FFO to range between $1.84 and $1.87 per diluted common share. The Company expects AFFO for fiscal 2013 to range between $1.49 and $1.52 per diluted common share and Normalized AFFO to range between $1.75 and $1.78 per diluted common share. The Company expects net income attributable to common stockholders for fiscal 2013 to range between $0.67 and $0.70 per diluted common share.
The Company's guidance excludes the impact of investments that may be made during the remainder of 2013. Except as otherwise noted above, the foregoing projections reflect management's view of current and future market conditions. There can be no assurance that the Company's actual results will not differ materially from the estimates set forth above. Except as otherwise required by law, the Company assumes no, and hereby disclaims any, obligation to update any of the foregoing projections as a result of new information or new or future developments.
The table below sets forth Sabra's updated 2013 full year guidance compared to its previously issued guidance:

 
 
Updated Guidance
 
Previously Issued Guidance
 
 
Low
 
High
 
Low
 
High
Net income attributable to common stockholders

 
$
0.67

 
$
0.70

 
$
0.65

 
$
0.69

 
 
 
 
 
 
 
 
 
Add:
 
 
 
 
 
 
 
 
Depreciation and amortization
 
0.88

 
0.88

 
0.88

 
0.88

 
 
 
 
 
 
 
 
 
FFO
 
1.55

 
1.58

 
1.53

 
1.57

Normalizing items
 
0.29

 
0.29

 
0.26

 
0.26

Normalized FFO
 
$
1.84

 
$
1.87

 
$
1.79

 
$
1.83

 
 
 
 
 
 
 
 
 
FFO
 
$
1.55

 
$
1.58

 
$
1.53

 
$
1.57

Acquisition pursuit costs
 
0.04

 
0.04

 
0.02

 
0.02

Stock-based compensation expense
 
0.18

 
0.18

 
0.18

 
0.18

Straight-line rental income adjustments
 
(0.38
)
 
(0.38
)
 
(0.37
)
 
(0.37
)
Amortization of deferred financing costs
 
0.08

 
0.08

 
0.07

 
0.07

Amortization of debt premium
 
(0.02
)
 
(0.02
)
 
(0.01
)
 
(0.01
)
Change in fair value of contingent consideration
 
0.02

 
0.02

 
(0.01
)
 
(0.01
)
Non-cash portion of loss on extinguishment of debt
 
0.02

 
0.02

 
0.01

 
0.01

 
 
 
 
 
 
 
 
 
AFFO
 
1.49

 
1.52

 
1.42

 
1.46

Normalizing items
 
0.26

 
0.26

 
0.24

 
0.24

Normalized AFFO
 
$
1.75

 
$
1.78

 
$
1.66

 
$
1.70

 
 
 
 
 
 
 
 
 






See reporting definitions.
4
    



SABRA HEALTH CARE REIT, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(dollars in thousands, except per share data)
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2013
 
2012
 
2013
 
2012
Revenues:
 
 
 
 
 
 
 
Rental income
$
31,699

 
$
25,420

 
$
94,692

 
$
73,903

Interest and other income
1,227

 
618

 
2,531

 
979

 
 
 
 
 
 
 
 
Total revenues
32,926

 
26,038

 
97,223

 
74,882

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Expenses:
 
 
 
 
 
 
 
Depreciation and amortization
8,258

 
7,496

 
24,726

 
22,356

Interest
9,739

 
9,085

 
29,884

 
24,681

General and administrative
3,057

 
3,778

 
11,196

 
11,588

 
 
 
 
 
 
 
 
Total expenses
21,054

 
20,359

 
65,806

 
58,625

 
 
 
 
 
 
 
 
Other income (expense):
 
 
 
 
 
 
 
Loss on extinguishment of debt
(351
)
 
(453
)
 
(10,101
)
 
(703
)
Other income (expense)
300

 

 
(600
)
 

 
 
 
 
 
 
 
 
Total other income (expense)
(51
)
 
(453
)
 
(10,701
)
 
(703
)
 
 
 
 
 
 
 
 
Net income
11,821

 
5,226

 
20,716

 
15,554

 
 
 
 
 
 
 
 
Preferred stock dividends
(2,579
)
 

 
(5,406
)
 

 
 
 
 
 
 
 
 
Net income attributable to common stockholders
$
9,242

 
$
5,226

 
$
15,310

 
$
15,554

 
 
 
 
 
 
 
 
 
 

 
 

 
 

 
 
Net income attributable to common stockholders, per:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic common share
$
0.25

 
$
0.14

 
$
0.41

 
$
0.42

 
 
 
 
 
 
 
 
Diluted common share
$
0.24

 
$
0.14

 
$
0.41

 
$
0.42

 
 
 
 
 
 
 
 
Weighted-average number of common shares outstanding, basic
37,358,334

 
37,178,162

 
37,334,120

 
37,121,384

 
 
 
 
 
 
 
 
Weighted-average number of common shares outstanding, diluted
37,828,573

 
37,465,114

 
37,777,458

 
37,276,013

 
 
 
 
 
 
 
 


 


See reporting definitions.
5
    



SABRA HEALTH CARE REIT, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(dollars in thousands, except per share data)
 

 
September 30,
2013
 
December 31,
2012
 
 
 
 
Assets
 
 
 
Real estate investments, net of accumulated depreciation of $153,792 and $129,479 as of September 30, 2013 and December 31, 2012, respectively
$
809,271

 
$
827,135

Loans receivable and other investments, net
46,123

 
12,017

Cash and cash equivalents
96,641

 
17,101

Restricted cash
6,809

 
4,589

Deferred tax assets
24,212

 
24,212

Assets held for sale, net

 
2,215

Prepaid expenses, deferred financing costs and other assets
44,194

 
29,613

Total assets
$
1,027,250

 
$
916,882

Liabilities and stockholders’ equity
 
 
 
Mortgage notes
$
142,241

 
$
152,322

Secured revolving credit facility

 
92,500

Senior unsecured notes
414,538

 
330,666

Accounts payable and accrued liabilities
23,069

 
11,694

Tax liability
24,212

 
24,212

Total liabilities
604,060

 
611,394

Stockholders’ equity
 
 
 
Preferred stock, $.01 par value; 10,000,000 shares authorized, 5,750,000 and zero shares issued and outstanding as of September 30, 2013 and December 31, 2012, respectively
58

 

Common stock, $.01 par value; 125,000,000 shares authorized, 37,333,943 and 37,099,209 shares issued and outstanding as of September 30, 2013 and December 31, 2012, respectively
373

 
371

Additional paid-in capital
494,802

 
353,861

Cumulative distributions in excess of net income
(72,043
)
 
(48,744
)
Total stockholders’ equity
423,190

 
305,488

Total liabilities and stockholders’ equity
$
1,027,250

 
$
916,882





 


See reporting definitions.
6
    



SABRA HEALTH CARE REIT, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
 
Nine Months Ended September 30,
 
2013
 
2012
Cash flows from operating activities:

 
 
Net income
$
20,716

 
$
15,554

Adjustments to reconcile net income to net cash provided by operating activities:

 
 
Depreciation and amortization
24,726

 
22,356

Non-cash interest income adjustments
29

 
18

Amortization of deferred financing costs
2,395

 
1,917

Stock-based compensation expense
5,209

 
5,749

Amortization of premium
(535
)
 
(151
)
Loss on extinguishment of debt
858

 
703

Straight-line rental income adjustments
(10,836
)
 
(2,857
)
Change in fair value of contingent consideration
600

 

Changes in operating assets and liabilities:


 
 
Prepaid expenses and other assets
(1,494
)
 
116

Accounts payable and accrued liabilities
10,413

 
7,211

Restricted cash
(2,870
)
 
(2,714
)

 
 
 
Net cash provided by operating activities
49,211

 
47,902


 
 
 
Cash flows from investing activities:

 
 
Acquisitions of real estate
(6,175
)
 
(98,050
)
Origination of loans receivable
(26,393
)
 
(22,111
)
Preferred equity investment
(6,624
)
 

Additions to real estate
(388
)
 
(1,039
)
Net proceeds from the sale of real estate
2,208

 


 
 
 
Net cash used in investing activities
(37,372
)
 
(121,200
)

 
 
 
Cash flows from financing activities:

 
 
Proceeds from issuance of senior unsecured notes
200,000

 
106,000

Principal payments on senior unsecured notes
(113,750
)
 

Proceeds from secured revolving credit facility

 
42,500

Payments on secured revolving credit facility
(92,500
)
 
(42,500
)
Proceeds from mortgage notes

 
35,829

Principal payments on mortgage notes
(10,081
)
 
(36,701
)
Payments of deferred financing costs
(8,598
)
 
(7,045
)
Issuance of preferred stock
138,257

 

Issuance of common stock
(2,950
)
 
144

Dividends paid on common and preferred stock
(42,677
)
 
(36,702
)

 
 
 
Net cash provided by financing activities
67,701

 
61,525


 
 
 
Net increase (decrease) in cash and cash equivalents
79,540

 
(11,773
)
Cash and cash equivalents, beginning of period
17,101

 
42,250


 
 
 
Cash and cash equivalents, end of period
$
96,641

 
$
30,477


 
 
 
Supplemental disclosure of cash flow information:

 
 
Interest paid
$
21,937

 
$
17,116


 
 
 

See reporting definitions.
7
    



SABRA HEALTH CARE REIT, INC.
RECONCILIATIONS OF EBITDA, ADJUSTED EBITDA, FUNDS FROM OPERATIONS (FFO), NORMALIZED FFO, ADJUSTED FUNDS FROM OPERATIONS (AFFO) AND NORMALIZED AFFO
(dollars in thousands, except per share data) 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2013
 
2012
 
2013
 
2012
Net income
$
11,821

 
$
5,226

 
$
20,716

 
$
15,554

Interest expense
9,739

 
9,085

 
29,884

 
24,681

Depreciation and amortization
8,258

 
7,496

 
24,726

 
22,356

EBITDA
$
29,818

 
$
21,807

 
$
75,326

 
$
62,591

 
 
 
 
 
 
 
 
Loss on extinguishment of debt
351

 
453

 
10,101

 
703

Change in fair value of contingent consideration
(300
)
 

 
600

 

Adjusted EBITDA
$
29,869

 
$
22,260

 
$
86,027

 
$
63,294

 
 
 
 
 
 
 
 
Net income attributable to common stockholders
$
9,242

 
$
5,226

 
$
15,310

 
$
15,554

Add:
 
 
 
 
 
 
 
Depreciation of real estate assets
8,258

 
7,496

 
24,726

 
22,356

Funds from Operations (FFO)
$
17,500

 
$
12,722

 
$
40,036

 
$
37,910

 
 
 
 
 
 
 
 
Loss on extinguishment of debt
351

 
453

 
10,101

 
703

Additional interest on 2018 Notes

 

 
770

 

Normalized FFO
$
17,851

 
$
13,175

 
$
50,907

 
$
38,613

 
 
 
 
 
 
 
 
FFO
$
17,500

 
$
12,722

 
$
40,036

 
$
37,910

Acquisition pursuit costs
281

 
367

 
707

 
1,239

Stock-based compensation expense
1,276

 
1,907

 
5,209

 
5,749

Straight-line rental income adjustments
(3,536
)
 
(1,167
)
 
(10,836
)
 
(2,857
)
Amortization of deferred financing costs
806

 
720

 
2,395

 
1,917

Amortization of debt premiums
(134
)
 
(143
)
 
(535
)
 
(151
)
Change in fair value of contingent consideration
(300
)
 

 
600

 

Non-cash portion of loss on extinguishment of debt
351

 
453

 
859

 
703

Non-cash interest income adjustments
17

 
9

 
29

 
18

Adjusted Funds from Operations (AFFO)
$
16,261

 
$
14,868

 
$
38,464

 
$
44,528

 
 
 
 
 
 
 
 
Cash portion of loss on extinguishment of debt

 

 
9,242

 

Additional interest on 2018 Notes

 

 
770

 

Normalized AFFO
$
16,261

 
$
14,868

 
$
48,476

 
$
44,528

 
 
 
 
 
 
 
 
Net income per diluted common share
$
0.24

 
$
0.14

 
$
0.41

 
$
0.42

 
 
 
 
 
 
 
 
FFO per diluted common share
$
0.46

 
$
0.34

 
$
1.06

 
$
1.02

 
 
 
 
 
 
 
 
Normalized FFO per diluted common share
$
0.47

 
$
0.35

 
$
1.35

 
$
1.04

 
 
 
 
 
 
 
 
AFFO per diluted common share
$
0.43

 
$
0.39

 
$
1.01

 
$
1.18

 
 
 
 
 
 
 
 
Normalized AFFO per diluted common share
$
0.43

 
$
0.39

 
$
1.27

 
$
1.18

 
 
 
 
 
 
 
 
Weighted average number of common shares outstanding, diluted:
 
 
 
 
 
 
 
Net income, FFO and Normalized FFO
37,828,573

 
37,465,114

 
37,777,458

 
37,276,013

AFFO and Normalized AFFO
38,065,299

 
37,748,716

 
38,067,386

 
37,660,657

 

See reporting definitions.
8
    



SABRA HEALTH CARE REIT, INC.
CAPITALIZATION
(dollars in thousands, except per share data)

Debt
September 30, 2013
 
December 31, 2012
Mortgage notes
$
142,241

 
$
152,322

Senior unsecured notes
414,538

 
330,666

Revolving credit facility

 
92,500

 
 
 
 
Total debt
$
556,779

 
$
575,488

 

Revolving Credit Facility
September 30, 2013
 
December 31, 2012
Current credit facility availability
$
286,477

 
$
109,130

Unused credit facility capacity
375,000

 
137,500


Enterprise Value
 
 
 
 
 
As of September 30, 2013
Shares
Outstanding
 
Price
 
Value
Common stock
37,333,943

 
$
23.01

 
$
859,054

Preferred stock
5,750,000

 
23.75

 
136,563

Total debt
 
 
 
 
556,779

Cash and cash equivalents
 
 
 
 
(96,641
)
 
 
 
 
 
 
Total enterprise value
 
 
 
 
$
1,455,755

 
 
 
 
 
 
As of December 31, 2012
Shares
Outstanding
 
Price
 
Value
Common stock
37,099,209

 
$
21.72

 
$
805,795

Total debt
 
 
 
 
575,488

Cash and cash equivalents
 
 
 
 
(17,101
)
 
 
 
 
 
 
Total enterprise value
 
 
 
 
$
1,364,182

 
 
 
 
 
 
 

Common Stock and Equivalents
 
 
 
 
 
 
 
 
 
 
Weighted Avg. Common Shares
Three Months Ended September 30, 2013
 
Nine Months Ended September 30, 2013
EPS & FFO
 
AFFO
 
EPS & FFO
 
AFFO
Common stock
 
37,333,943

 
37,333,943

 
37,292,852

 
37,292,852

Common equivalents
 
24,391

 
24,391

 
41,268

 
41,268

 
 
 
 
 
 
 
 
 
Basic common and common equivalents
 
37,358,334

 
37,358,334

 
37,334,120

 
37,334,120

Dilutive securities:
 
 
 
 
 
 
 
 
Restricted stock and units
 
454,871

 
687,630

 
417,727

 
701,729

Options
 
15,368

 
19,335

 
25,611

 
31,537

 
 
 
 
 
 
 
 
 
Diluted common and common equivalents
 
37,828,573

 
38,065,299

 
37,777,458

 
38,067,386

 
 
 
 
 
 
 
 
 





See reporting definitions.
9
    



SABRA HEALTH CARE REIT, INC.
INDEBTEDNESS
September 30, 2013
(dollars in thousands)
 
Principal
 
Weighted
Average
Effective Rate
 
% of Total
Fixed rate debt
 
 
 
 
 
Secured mortgage debt (1)
$
85,247

  
4.01
%
 
15.3
%
Unsecured senior notes (2)
414,538

  
6.60
%
 
74.5
%
 
 
 
 
 
 
Total fixed rate debt
499,785

  
6.16
%
 
89.8
%
 
 
 
 
 
 
Variable rate debt
 
 
 
 
 
Secured mortgage debt(3)
56,994

  
5.00
%
 
10.2
%
Revolving credit facility (4)

  
3.18
%
 
%
 
 
 
 
 
 
Total variable rate debt
56,994

  
5.00
%
 
10.2
%
 
 
 
 
 
 
Total debt
$
556,779

  
6.04
%
 
100.0
%
 
 
 
 
 
Secured debt
 
 
 
 
 
Secured mortgage debt
$
142,241

  
4.41
%
 
25.5
%
Revolving credit facility (4)

  
3.18
%
 
%
 
 
 
 
 
 
Total secured debt
142,241

  
4.41
%
 
25.5
%
 
 
 
 
 
 
Unsecured debt
 
 
 
 
 
Unsecured senior notes (2)
414,538

  
6.60
%
 
74.5
%
 
 
 
 
 
 
Total unsecured debt
414,538

  
6.60
%
 
74.5
%
 
 
 
 
 
 
Total debt
$
556,779

  
6.04
%
 
100.0
%
 
Maturities
 
Secured Mortgage Debt
 
Unsecured Senior Notes
 
Revolving Credit Facility
  
Total
 
Principal
 
Rate (5)
 
Principal
 
Rate (5)
 
Principal
 
Rate (5)
  
Principal
 
Rate (5)
October 1 through December 31, 2013
$
912

 
4.44
%
 
$

 

  
$

 
  
$
912

 
4.44
%
2014
3,739

 
4.45
%
 

 

  

 
  
3,739

 
4.45
%
2015
86,075

 
3.79
%
 

 

  

 
  
86,075

 
3.79
%
2016
1,647

 
2.47
%
 

 

  

 
  
1,647

 
2.47
%
2017
1,688

 
2.47
%
 

 

  

 
  
1,688

 
2.47
%
2018
1,730

 
2.47
%
 
211,250

 
8.13
%
  

 
  
212,980

 
8.08
%
2019
1,774

 
2.47
%
 

 

  

 
  
1,774

 
2.47
%
2020
1,818

 
2.47
%
 

 

 

 
  
1,818

 
2.47
%
2021
1,863

 
2.47
%
 

 

  

 
  
1,863

 
2.47
%
2022
1,910

 
2.46
%
 

 

  

 
  
1,910

 
2.46
%
Thereafter
39,085

 
2.46
%
 
200,000

 
5.38
%
  

 
  
239,085

 
4.90
%
 
142,241

 
 
 
411,250

 
 
 

 
 
  
553,491

 
 
Premium

 
 
 
3,288

 
 
 

 
 
  
3,288

 
 
Total debt
$
142,241

 
 
 
$
414,538

 
 
 
$

 
 
  
$
556,779

 
 
Weighted average maturity in years
11.6

 
 
 
7.3

 
 
 
2.8

 
 
  
8.4

 
 
Weighted average effective interest rate
4.41
%
 
 
 
6.60
%
 
 
 
3.18
%
 
 
  
6.04
%
 
 
(1) Fixed rate secured mortgage debt includes $30.2 million which converts to a variable interest rate based on 90-day LIBOR plus 4.0% (1.00% floor) effective January 2014. This debt matures in August 2015.
(2) Unsecured senior notes includes $3.3 million of notes premium.
(3) Variable rate secured mortgage debt interest is based on 90-day LIBOR plus 4.0% (1.00% floor).
(4) Borrowings under the revolving credit facility bear interest on the outstanding principal amount at a rate equal to, at our option, LIBOR plus 2.50% - 3.50% or a Base Rate plus 1.50% - 2.50%. The actual interest rate within the applicable range was determined based on our then applicable Consolidated Leverage Ratio.
(5) Represents actual contractual interest rates.

See reporting definitions.
10
    



SABRA HEALTH CARE REIT, INC.
DEBT COVENANTS
(dollars in millions)
 
 
 
 
 
 
 
 
 
 
 
Minimum
 
Maximum
 
September 30, 2013
 
December 31, 2012
 
Credit Facility:
 
 
 
 
 
 
 
 
Consolidated Leverage Ratio
 
 
5.50x

 
4.43x

 
4.71x

 
Consolidated Fixed Charge Coverage Ratio
1.75x

 
 
 
2.49x

 
2.92x

 
Consolidated Tangible Net Worth (1)
$
452.7

 
 
 
$
560.9

 
$
422.4

 
Limitation on Secured Indebtedness
 
 
30
%
 
11
%
 

 
 
 
 
 
 
 
 
 
 
Unsecured Senior Notes:
 
 
 
 
 
 
 
 
Total Debt/ Asset Value
 
 
60
%
 
47
%
 
48
%
 
Secured Debt/ Asset Value
 
 
40
%
 
19
%
 
21
%
 
Unencumbered Assets/ Unsecured Debt
150
%
 
 
 
188
%
 
183
%
 
Minimum Interest Coverage
2.00x

 
 
 
4.05
x
 
3.22x

 
(1) Consolidated Tangible Net Worth Minimum as of December 31, 2012 was $342.0
Note: All covenants are based on terms defined in the related credit agreement (as amended) and unsecured senior notes indentures. Asset Value and Unencumbered Assets used for debt covenant calculation purposes include a value for the initial real estate portfolio obtained in the separation from Sun, which is calculated by dividing the total initial annual rental revenue from this portfolio by an assumed 9.75% capitalization rate. This results in an assumed total portfolio value for the initial real estate portfolio of $720 million.
 





See reporting definitions.
11
    



SABRA HEALTH CARE REIT, INC.
PORTFOLIO SUMMARY - ALL INVESTMENTS
September 30, 2013
(dollars in thousands)
 
 
 
 
 
 
Rental Income (1)
 
Number of
Licensed
Beds/Units
 
Occupancy Percentage (2)
 
 
 
 
 
 
Three Months Ended September 30,
 
 
Three Months Ended September 30,
Facility Type
 
Number of
Properties
 
Investment
 
2013
 
2012
 
 
2013
 
2012
Skilled Nursing/Post-Acute
 
96

 
$
746,897

 
$
26,218

 
$
22,472

 
10,826

 
88.0
%
 
89.5
%
Senior Housing
 
23

 
154,272

 
3,834

 
1,300

 
1,518

 
87.9
%
 
83.6
%
Acute Care Hospital
 
1

 
61,640

 
1,648

 
1,648

 
70

 
69.8
%
 
65.4
%
Total 
 
120

 
$
962,809

 
$
31,699

 
$
25,420

 
12,414

 
87.9
%
 
89.0
%

 
 
EBITDAR Coverage (2)
 
EBITDARM Coverage (2)
 
 
Three Months Ended September 30,
 
Twelve Months Ended September 30,
 
Three Months Ended September 30,
 
Twelve Months Ended September 30,
Facility Type
 
2013
 
2012
 
2013
 
2012
 
2013
 
2012
 
2013
 
2012
Skilled Nursing/Post-Acute
 
1.27x
 
1.27x
 
1.27x
 
1.33x
 
1.73x
 
1.75x
 
1.75x
 
1.82x
Senior Housing
 
1.18x
 
1.22x
 
1.17x
 
1.26x
 
1.42x
 
1.49x
 
1.40x
 
1.55x
Acute Care Hospital
 
2.71x
 
2.29x
 
2.43x
 
2.50x
 
2.78x
 
2.39x
 
2.52x
 
2.62x
Total
 
1.33x
 
1.33x
1.32

1.32x
 
1.40x
 
1.75x
 
1.77x
 
1.75x
 
1.86x
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Fixed Charge Coverage Ratio (3)
 
Three Months Ended September 30, 2013
Genesis
 
1.29x

 
 
Nine Months Ended September 30,
Total Revenue
 
2013
 
2012
Genesis
  
62.4
%
 
72.1
%
Cadia Portfolio
 
8.2

 
10.6

Texas Regional Medical Center
 
5.1

 
6.6

Meridian
 
4.8

 
0.8

Aurora
 
3.6

 
3.3

Other
 
15.9

 
6.6

Total
 
100.0
%
 
100.0
%

  









(1) Rental income includes $3.5 million and $1.2 million of straight-line rental income adjustments for the three months ended September 30, 2013 and September 30, 2012, respectively.
(2) Occupancy percentage, EBITDARM, EBITDAR and related coverages are only included in periods subsequent to our acquisition of the facilities for facilities with new tenants/ operators and exclude the impact of strategic disposition candidates and non-stabilized properties. All facility financial performance data are presented one quarter in arrears.
(3) As of September 30, 2013, 81 of the Company's 120 properties held for investment were operated by and leased to subsidiaries of Genesis pursuant to triple-net leases that are guaranteed by Genesis. Fixed Charge Coverage Ratio is presented one quarter in arrears. See Reporting Definitions for definitions of Fixed Charge Coverage.
SABRA HEALTH CARE REIT, INC.
PORTFOLIO SUMMARY - ALL INVESTMENTS (CONTINUED)
September 30, 2013
(dollars in thousands)


Loan Type
Number of Loans
 
Facility Type
 
Principal Balance as of September 30, 2013
 
Book Value as of September 30, 2013
 
Weighted Average Contractual Interest Rate
 
Weighted Average Annualized Effective Interest Rate
 
Interest Income Three Months Ended September 30, 2013
Maturity Date
Mortgage
2

 
Skilled Nursing / Senior Housing
 
$
24,394

 
$
24,505

 
8.8
%
 
8.7
%
 
$
543

6/30/17 - 1/31/18
Mezzanine
1

 
Skilled Nursing
 
12,350

 
12,424

 
12.0
%
 
11.5
%
 
365

12/27/14
Pre-development
2

 
Senior Housing
 
1,338

 
1,362

 
9.0
%
 
9.0
%
 
23

8/16/15 - 9/13/16
Construction Mortgage
1

 
Acute Care Hospital
 
520

 
742

 
7.3
%
 
7.1
%
 

9/30/16
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6

 
 
 
$
38,602

 
$
39,033

 
9.8
%
 
9.6
%
 
$
931

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 


Other Investment Type
 
Number of Investments
 
Facility Type
 
Total Funding Commitments
 
Amount Funded
 as of
September 30, 2013
 
Book Value
as of
September 30, 2013
 
Rate of Return
 
Other Income
Three Months Ended
September 30, 2013
Preferred Equity
 
2
 
Skilled Nursing/Memory Care
 
$
7,243

 
$
6,537

 
$
7,090

 
15.0
%
 
$
237




                                          



See reporting definitions.
12
    



SABRA HEALTH CARE REIT, INC.
PORTFOLIO SUMMARY - SAME STORE (1) 
September 30, 2013
(dollars in thousands)
 
 
 
 
Three Months Ended September 30,
 
 
 
 
Rental Income (2)
 
Occupancy Percentage (3)
 
Skilled Mix (3)
Facility Type
 
Number of
Properties
 
2013
 
2012
 
2013
 
2012
 
2013
 
2012
Skilled Nursing/Post-Acute
 
95

 
$
24,853

 
$
22,473

 
88.3
%
 
89.5
%
 
36.1
%
 
37.3
%
Senior Housing
 
10

 
1,376

 
1,188

 
85.5
%
 
83.6
%
 
N/A

 
N/A

Acute Care Hospital
 
1

 
1,648

 
1,648

 
69.8
%
 
65.4
%
 
N/A

 
N/A

Total
 
106

 
$
27,877

 
$
25,309

 
88.0
%
 
89.0
%
 
36.1
%
 
37.3
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
EBITDAR Coverage (3)
 
EBITDARM Coverage (3)
 
 
Three Months Ended September 30,
 
Twelve Months Ended September 30,
 
Three Months Ended September 30,
 
Twelve Months Ended September 30,
Facility Type
 
2013
 
2012
 
2013
 
2012
 
2013
 
2012
 
2013
 
2012
Skilled Nursing/Post-Acute
 
1.26x
 
1.27x
 
1.27x
 
1.33x
 
1.74x
 
1.75x
 
1.75x
 
1.82x
Senior Housing
 
1.15x
 
1.35x
 
1.30x
 
1.30x
 
1.44x
 
1.65x
 
1.60x
 
1.60x
Acute Care Hospital
 
2.71x
 
2.29x
 
2.43x
 
2.50x
 
2.78x
 
2.39x
 
2.52x
 
2.62x
Total
 
1.34x
 
1.33x
 
1.34x
 
1.40x
 
1.78x
 
1.78x
 
1.79x
 
1.86x
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 



































(1) Same Store statistics consist of facilities held or acquired before July 1, 2012 and exclude the impact of strategic disposition candidates and non-stabilized properties.
(2) Rental income includes $3.0 million and $1.2 million of straight-line rental income adjustments for the three months ended September 30, 2013 and September 30, 2012, respectively.
(3) Occupancy percentage, skilled mix, EBITDARM, EBITDAR and related coverages are only included in periods subsequent to our acquisition of the facilities for facilities with new tenants/operators and exclude the impact of strategic disposition candidates and non-stabilized properties. All facility financial performance data are presented one quarter in arrears.

See reporting definitions.
13
    



SABRA HEALTH CARE REIT, INC.
INVESTMENT ACTIVITY
For the Nine Months Ended September 30, 2013
(dollars in thousands)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investment Date
Facility Type
Number of Properties
 
Beds
 
Total Commitment
 
Investment as of September 30, 2013
 
Rate of Return
Real Estate Investments
 
 
 
 
 
 
 
 
 
 
 
   Greenfield of Woodstock
06/28/13
Senior Housing
1

 
32

 
$
6,175

 
$
6,175

 
7.75
%
Preferred Equity Investments (1)
 
 
 
 
 
 
 
 
 
 
 
Bee Cave - SNF (2)
03/05/13
Skilled Nursing
1

 
141

 
4,337

 
3,723

 
15.00
%
Bee Cave - ALZ
03/05/13
Memory Care
1

 
52

 
2,905

 
2,814

 
15.00
%
Total Preferred Equity Investments
 
 
 
 


 
7,242

 
6,537

 
15.00
%
Debt Investments
 
 
 
 
 
 

 
 
 
 
Sun City West Mortgage Loan
01/31/13
Memory Care
1

 
48

 
12,800

 
12,800

 
9.00
%
Chai Portfolio Mezzanine Loan (3)
06/28/13
Skilled Nursing
12

 
1,689

 
12,350

 
12,350

 
12.000
%
Marshfield II Pre-Development Loan
09/13/13
Memory Care
1

 
24

 
373

 
373

 
9.00
%
Forest Park - Fort Worth Construction Mortgage Loan (4)
09/30/13
Acute Care Hospital
1

 
54

 
66,800

 
520

 
7.25
%
Total Debt Investments
 
 
 
 


 
92,323

 
26,043

 
8.14
%
All Investments (Total:7)
 
 


 


 
$
105,740

 
$
38,755

 
8.58
%

Annualized Revenue Concentration (5) 


Annualized Revenue by Asset Class (5)
                                                         
(1) Investments in preferred equity of real estate development entities.
(2) 
Includes an option to purchase the skilled nursing facility on or after the earlier to occur of the facility achieving and maintaining 90% occupancy for three consecutive months, or 36 months after receiving the certificate of occupancy for the facility.
(3) Includes an option to purchase up to $50.0 million of assets from the Chai portfolio.
(4) Includes a purchase option that will be exercisable starting twelve months after receiving a certificate of occupancy through and until the maturity date of the loan.
(5) Annualized Revenue Concentration and Annualized Revenue by Asset Class reflect only amounts invested as of September 30, 2013.

See reporting definitions.
14
    




SABRA HEALTH CARE REIT, INC.
REAL ESTATE PORTFOLIO GEOGRAPHIC CONCENTRATIONS
September 30, 2013
 
Property Type  
State
 
Skilled Nursing/Post-Acute
 
Senior Housing
  
Acute Care Hospital
  
Total
 
% of Total
New Hampshire
 
14

 
2

 

 
16

 
13.3
%
Kentucky
 
13

 
2

 

 
15

 
12.5

Connecticut
 
12

 
1

 

 
13

 
10.8

Michigan
 

 
10

 

 
10

 
8.3

Ohio
 
8

 

 

 
8

 
6.7

Texas
 
6

 
1

 
1

 
8

 
6.7

Florida
 
5

 

 

 
5

 
4.2

Oklahoma
 
3

 
1

 

 
4

 
3.3

Delaware
 
4

 

 

 
4

 
3.3

Montana
 
4

 

 

 
4

 
3.3

Other (17 states)
 
27

 
6

 

 
33

 
27.6

 
 
 
 
 
 
 
 
 
 
 
Total
 
96

 
23

 
1

 
120

 
100.0
%
 
 
 
 
 
 
 
 
 
 
 
% of Total properties
 
80.0
%
 
19.2
%
 
0.8
%
 
100.0
%
 
 
 
 
 
  
 
 
 
 
 
 
 
 
Distribution of Licensed Beds/Units
 
 
Total Number of
Properties
 
Bed/Unit Type
 
 
 
State
 
 
Skilled Nursing/Post-Acute
 
Senior Housing
  
Acute Care Hospital
 
Total
 
% of Total
Connecticut
 
13

 
1,770

 
49

 

 
1,819

 
14.7
%
New Hampshire
 
16

 
1,470

 
203

 

 
1,673

 
13.5

Kentucky
 
15

 
1,020

 
128

 

 
1,148

 
9.2

Ohio
 
8

 
897

 

 

 
897

 
7.2

Texas
 
8

 
720

 
34

 
70

 
824

 
6.6

Florida
 
5

 
660

 

 

 
660

 
5.3

Michigan
 
10

 

 
571

 

 
571

 
4.6

Montana
 
4

 
538

 

 

 
538

 
4.3

Delaware
 
4

 
500

 

 

 
500

 
4.0

Colorado
 
3

 
362

 
48

 

 
410

 
3.3

Other (17 states)
 
34

 
2,889

 
485

 

 
3,374

 
27.3

 
 
 
 
 
 
 
 
 
 
 
 
 
Total
 
120

 
10,826

 
1,518

 
70

 
12,414

 
100.0
%
 
 
 
 
 
 
 
 
 
 
 
 
 
% of Total beds/units
 
 
 
87.2
%
 
12.2
%
 
0.6
%
 
100.0
%
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 


See reporting definitions.
15
    



SABRA HEALTH CARE REIT, INC.
REAL ESTATE PORTFOLIO GEOGRAPHIC CONCENTRATIONS
September 30, 2013
(dollars in thousands)

Investment
State
 
Total Number of Properties
 
Skilled Nursing/Post-Acute
 
Senior Housing
  
Acute Care Hospital
  
Total
 
% of Total
Connecticut
 
13

 
$
143,992

 
$
7,999

 
$

 
$
151,991

 
15.8
%
Texas
 
8

 
65,795

 
1,396

 
61,640

 
128,831

 
13.4

Delaware
 
4

 
95,780

 

 

 
95,780

 
9.9

New Hampshire
 
16

 
76,992

 
12,792

 

 
89,784

 
9.3

Michigan
 
10

 

 
73,968

 

 
73,968

 
7.7

Kentucky
 
15

 
59,350

 
10,489

 

 
69,839

 
7.3

Colorado
 
3

 
28,852

 
15,702

 

 
44,554

 
4.6

Montana
 
4

 
42,729

 

 

 
42,729

 
4.4

Ohio
 
8

 
42,612

 

 

 
42,612

 
4.4

Florida
 
5

 
30,748

 

 

 
30,748

 
3.2

Other (17 states)
 
34

 
160,047

 
31,926

 


 
191,973

 
20.0

 
 
 
 
 
 
 
 
 
 
 
 
 
Total
 
120

 
$
746,897

 
$
154,272

 
$
61,640

 
$
962,809

 
100.0
%
 
 
 
 
 
 
 
 
 
 
 
 
 
% of Total Properties
 
 
 
77.6
%
 
16.0
%
 
6.4
%
 
100.0
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 




























See reporting definitions.
16
    



SABRA HEALTH CARE REIT, INC.
REAL ESTATE PORTFOLIO GEOGRAPHIC CONCENTRATIONS
September 30, 2013
(dollars in thousands)

Rental Income - Three Months Ended September 30, 2013
State
 
Total Number of Properties
 
Skilled Nursing/Post-Acute
  
Senior Housing
  
Acute Care Hospital
  
Total
  
% of Total
New Hampshire
 
16

 
$
3,465

 
$
391

 
$

 
$
3,856

 
12.2
%
Connecticut
 
13

 
3,773

 
83

 

 
3,856

 
12.2

Texas
 
8

 
1,877

 
25

 
1,648

 
3,550

 
11.2

Kentucky
 
15

 
2,876

 
145

 

 
3,021

 
9.5

Delaware
 
4

 
2,644

 

 

 
2,644

 
8.3

Florida
 
5

 
2,204

 

 

 
2,204

 
7.0

Michigan
 
10

 

 
1,730

 

 
1,730

 
5.5

Montana
 
4

 
1,483

 

 

 
1,483

 
4.7

Ohio
 
8

 
1,471

 

 

 
1,471

 
4.6

Colorado
 
3

 
941

 
367

 

 
1,307

 
4.1

Other (17 states)
 
34

 
5,484

 
1,093

 

 
6,577

 
20.7

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
120

 
$
26,218

 
$
3,834

 
$
1,648

 
$
31,699

 
100.0
%
 
 
 
 
 
 
 
 
 
 
 
 
 
% of Total Properties
 
 
 
82.7
%
 
12.1
%
 
5.2
%
 
100.0
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Rental Income - Nine Months Ended September 30, 2013
State
 
Total Number of Properties
 
Skilled Nursing/Post-Acute
  
Senior Housing
  
Acute Care Hospital
  
Total
  
% of Total
New Hampshire
 
16

 
10,394

 
1,173

 

 
11,567

 
12.2
%
Connecticut
 
13

 
11,318

 
249

 

 
11,567

 
12.2

Texas
 
8

 
5,631

 
74

 
4,945

 
10,650

 
11.2

Kentucky
 
15

 
8,545

 
433

 

 
8,978

 
9.5

Delaware
 
4

 
7,934

 

 

 
7,934

 
8.4

Florida
 
5

 
6,613

 

 

 
6,613

 
7.0

Michigan
 
10

 

 
5,190

 

 
5,190

 
5.5

Montana
 
4

 
4,449

 

 

 
4,449

 
4.7

Ohio
 
8

 
4,413

 

 

 
4,413

 
4.7

Colorado
 
3

 
2,822

 
1,100

 

 
3,922

 
4.1

Other (17 states)
 
34

 
16,437

 
2,972

 

 
19,409

 
20.5

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
120

 
$
78,556

 
$
11,191

 
$
4,945

 
$
94,692

 
100.0
%
 
 
 
 
 
 
 
 
 
 
 
 
 
% of Total Properties
 
 
 
83.0
%
 
11.8
%
 
5.2
%
 
100.0
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 



See reporting definitions.
17
    



SABRA HEALTH CARE REIT, INC.
SKILLED MIX AND OCCUPANCY PERCENTAGE
 
 
Skilled Mix (1)
 
Three Months Ended September 30,
 
Twelve Months Ended September 30,
 
Year Ended December 31,
 
2013
 
2012
 
2013
 
2012
 
2012
 
2011
 
2010
Skilled Nursing
36.4
%
 
37.3
%
 
36.8
%
 
38.7
%
 
38.0
%
 
41.4
%
 
39.5
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Occupancy Percentage (1)
 
Three Months Ended September 30,
 
Twelve Months Ended September 30,
 
Year Ended December 31,
 
2013
 
2012
 
2013
 
2012
 
2012
 
2011
 
2010
Skilled Nursing/Post-Acute
88.0
%
 
89.5
%
 
88.5
%
 
89.3
%
 
89.1
%
 
89.3
%
 
89.0
%
Senior Housing
87.9

 
83.6

 
87.3

 
83.5

 
86.1

 
82.8

 
84.4

Acute Care Hospital
69.8

 
65.4

 
68.1

 
67.3

 
66.9

 
72.9

 
N/A

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted Average
87.9
%
 
89.0
%
 
88.3
%
 
88.8
%
 
88.6
%
 
88.8
%
 
88.6
%
 


(1) Skilled mix and occupancy percentage for facilities with new tenants/operators are only included in periods subsequent to our acquisition of the facilities and exclude the impact of strategic disposition candidates and non-stabilized properties. All facility financial performance data are presented one quarter in arrears.







See reporting definitions.
18
    



SABRA HEALTH CARE REIT, INC.
PORTFOLIO LEASE EXPIRATIONS
September 30, 2013
(dollars in thousands)
 

 
2013 - 2019
 
2020
 
2021
 
2022
 
2023
 
2024
 
2025
 
Thereafter
 
Total
Skilled Nursing/Post-Acute
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Properties

 
27

 
30

 
12

 

 
1

 
4

 
22

 
96

Licensed Beds/Units

 
3,025

 
3,508

 
869

 
 
 
360

 
575

 
2,489

 
10,826

Annualized Revenues
$

 
$
27,061

 
$
30,831

 
$
10,147

 
$

 
$
2,134

 
$
5,141

 
$
29,569

 
$
104,883

Senior Housing
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Properties

 
2

 
3

 
14

 

 

 
1

 
3

 
23

Licensed Beds/Units

 
251

 
197

 
807

 

 

 
114

 
149

 
1,518

Annualized Revenues

 
1,974

 
1,501

 
9,723

 

 

 
837

 
1,353

 
15,388

Acute Care Hospital
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Properties

 

 

 

 

 

 

 
1

 
1

Licensed Beds/Units

 

 

 

 

 

 

 
70

 
70

Annualized Revenues

 

 

 

 

 

 

 
6,593

 
6,593

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total Properties

 
29

 
33

 
26

 

 
1

 
5

 
26

 
120

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total Licensed Beds/Units

 
3,276

 
3,705

 
1,676

 

 
360

 
689

 
2,708

 
12,414

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total Annualized Revenues
$

 
$
29,035

 
$
32,332

 
$
19,870

 
$

 
$
2,134

 
$
5,978

 
$
37,515

 
$
126,864

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
% of Revenue
%
 
23.0
%
 
25.5
%
 
15.7
%
 
%
 
1.7
%
 
4.7
%
 
29.4
%
 
100.0
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 


 



See reporting definitions.
19
    



SABRA HEALTH CARE REIT, INC.
RECENT INVESTMENT ACTIVITY

Marshfield II - Pre-Development Loan
• Funding Date:
 
September 13, 2013
 
 
 
• Loan Amount:
 
$0.4 million
 
 
 
• Investment Type:
 
Pre-Development Loan
 
 
 
• Number of Properties:
 
1
 
 
 
• Location:
 
Marshfield, Wisconsin
 
 
 
• Available Beds/Units:
 
24
 
 
 
• Property Type:
 
Memory Care
 
 
 
• Annualized GAAP Interest Income:
 
$33,600
 
 
 
• Rate of Return:
 
9.0%
 
 
 
• Maturity Date:
 
September 13, 2016


















See reporting definitions.
20
    






SABRA HEALTH CARE REIT, INC.
RECENT INVESTMENT ACTIVITY
Forest Park - Fort Worth Construction Mortgage Loan
• Funding Date:
 
September 30, 2013
 
 
 
• Loan Amount:
 
$66.8 million committed ($0.5 million funded as of September 30, 2013)
 
 
 
• Investment Type(1):
 
Construction Loan (with purchase option)
 
 
 
• Number of Properties:
 
1
 
 
 
• Location:
 
Fort Worth, Texas
 
 
 
• Available Beds/Units:
 
48 inpatient beds, 6 intensive care beds and 12 operating rooms
 
 
 
• Property Type:
 
Acute Care Hospital
 
 
 
• Annualized GAAP Interest Income:
 
$37,700 ($4.8 million when fully funded)
 
 
 
• Rate of Return:
 
7.25%
 
 
 
• Maturity Date:
 
September 30, 2016















(1) Includes an option to purchase the acute care hospital and associated parking structure starting 12 months after the facility receives a certificate of occupancy through and until the maturity date of the loan subject to certain limited rights of the borrower. The purchase price under the purchase option agreement will be calculated by dividing the contractual rent due under the existing facility lease over the twelve months following closing by the greater of (i) 8.75% and (ii) the sum of (x) the then current 10-year Treasury rate and (y) 525 basis points.

See reporting definitions.
21
    



SABRA HEALTH CARE REIT, INC.
RECENT INVESTMENT ACTIVITY
Forest Park Medical Center - Dallas



• Funding Date:
 
October 22, 2013
 
 
 
• Loan Amount:
 
$110.0 million
 
 
 
• Investment Type (1):
 
Mortgage Loan (with put/call option)
 
 
 
• Number of Properties:
 
1
 
 
 
• Location:
 
Dallas, Texas
 
 
 
• Available Beds/Units:
 
72 private beds,12 intensive care unit beds and 22 operating rooms
 
 
 
• Property Type:
 
Acute Care Hospital
 
 
 
• Annualized GAAP Interest Income:
 
$8.8 million
 
 
 
• Rate of Return:
 
8.00%
 
 
 
• Maturity Date:
 
October 22, 2016

















(1) Includes an option to purchase the facility securing the Forest Park - Dallas Mortgage Loan for up to $168.0 million. The borrowers under the Forest Park - Dallas Mortgage Loan have the right, if Forest Park Medical Center - Dallas is able to achieve certain EBITDAR coverage levels, to require us to purchase the facility for up to $168.0 million.

See reporting definitions.
22
    



SABRA HEALTH CARE REIT, INC.
RECENT INVESTMENT ACTIVITY
Forest Park Medical Center - Frisco


• Acquisition Date:
 
October 22, 2013
 
 
 
• Purchase Price (1):
 
$119.8 million
 
 
 
• Investment Type:
 
Equity
 
 
 
• Number of Properties:
 
1
 
 
 
• Location:
 
Frisco, Texas
 
 
 
• Available Beds/Units:
 
30 inpatient rooms, 14 family suites,10 intensive care unit beds and 12 operating rooms
 
 
 
• Property Type:
 
Acute Care Hospital
 
 
 
• Annualized GAAP Rental Income:
 
$13.3 million
 
 
 
• Initial Cash Yield:
 
8.75%






















(1) Upon the closing of the acquisition, approximately $10.5 million of the purchase price was being held in escrow for up to 20 months from the closing of the acquisition, the release of which is contingent on the tenant achieving certain performance hurdles.

See reporting definitions.
23
    



SABRA HEALTH CARE REIT, INC.
RECENT INVESTMENT ACTIVITY - PRO FORMA INFORMATION

Note: The following pro forma information assumes the investment activity during the quarter ending September 30, 2013 as described on page 15 of this Supplement, the entry into our new revolving credit facility, the acquisition of Forest Park Medical Center - Frisco and the origination of the Forest Park Medical Center - Dallas Mortgage Loan, were completed as of July 1, 2013. The following pro forma information does not include the impact of any future capital raising activity.

Pro Forma Net Income Attributable to Common Stockholders, FFO, Normalized FFO and AFFO (dollars in thousands, except per share data)
 
Three Months Ended September 30, 2013
 
Adjustments (1)
 
Pro-Forma Three Months Ended September 30, 2013
 
 
Investing
 
Financing
 
Net income attributable to common stockholders
$
9,242

 
$
4,075

 
$
(611
)
 
$
12,706

Add:
 
 
 
 
 
 
 
Depreciation of real estate assets
8,258

 
987

 

 
9,245

 
 
 
 
 
 
 
 
Funds from Operations (FFO)
$
17,500

 
$
5,062

 
$
(611
)
 
$
21,951

 
 
 
 
 
 
 
 
Loss on extinguishment of debt
351

 

 
(351
)
 

Normalized FFO
$
17,851

 
$
5,062

 
$
(962
)
 
$
21,951

 
 
 
 
 
 
 
 
FFO
$
17,500

 
$
5,062

 
$
(611
)
 
$
21,951

Acquisition pursuit costs
281

 
424

 

 
705

Stock-based compensation expense
1,276

 

 

 
1,276

Straight-line rental income adjustments
(3,536
)
 
(710
)
 

 
(4,246
)
Amortization of deferred financing costs
806

 

 
38

 
844

Amortization of debt premiums
(134
)
 

 

 
(134
)
Change in fair value of contingent consideration
(300
)
 

 

 
(300
)
Non-cash portion of loss on extinguishment of debt
351

 

 
(351
)
 

Non-cash interest income adjustments
17

 
31

 

 
48

Adjusted Funds from Operations (AFFO)
$
16,261

 
$
4,807

 
$
(924
)
 
$
20,144

 
 
 
 
 
 
 
 
Net income per diluted common share
$
0.24

 
$
0.11

 
$
(0.02
)
 
$
0.34

 
 
 
 
 
 
 
 
FFO per diluted common share
$
0.46

 
$
0.13

 
$
(0.02
)
 
$
0.58

 
 
 
 
 
 
 
 
Normalized FFO per diluted common share
$
0.47

 
$
0.13

 
$
(0.03
)
 
$
0.58

 
 
 
 
 
 
 
 
AFFO per diluted common share
$
0.43

 
$
0.13

 
$
(0.02
)
 
$
0.53

 
 
 
 
 
 
 
 
Weighted average number of common shares outstanding, diluted:
 
 
 
 
 
 
 
Net income, FFO and Normalized FFO
37,828,573

 
37,828,573

 
37,828,573

 
37,828,573

AFFO
38,065,299

 
38,065,299

 
38,065,299

 
38,065,299

 
 
 
 
 
 
 
 

(1) Adjustments related to investing activities include $3.3 million of pro forma rental income and $2.1 million of interest and other income. Adjustments related to financing activities include $1.0 million of interest expense.








SABRA HEALTH CARE REIT, INC.
RECENT INVESTMENT ACTIVITY - PRO FORMA INFORMATION (Continued)


Pro Forma Debt Covenants (dollars in millions)

 
 
 
 
 
 
 
 
 
Minimum
 
Maximum
 
Actual September 30, 2013
 
Pro Forma
Credit Facility:
 
 
 
 
 
 
 
Consolidated Leverage Ratio
 
 
5.50x

 
4.43x

 
4.65x

Consolidated Fixed Charge Coverage Ratio
1.75x

 
 
 
2.49x

 
2.74x

Consolidated Tangible Net Worth
$
452.7

 
 
 
$
560.9

 
$
560.9

Limitation on Secured Indebtedness
 
 
30
%
 
11
%
 
10
%
 
 
 
 
 
 
 


Unsecured Senior Notes:
 
 
 
 
 
 


Total Debt/ Asset Value
 
 
60
%
 
47
%
 
47
%
Secured Debt/ Asset Value
 
 
40
%
 
19
%
 
19
%
Unencumbered Assets/ Unsecured Debt
150
%
 
 
 
188
%
 
188
%
Minimum Interest Coverage
2.00x

 
 
 
4.05
x
 
3.72
x


Pro Forma Annualized Revenue Concentration

    
                                                                                                                                           
Pro Forma Annualized Revenue by Asset Class
                        





(1) Assumes the Forest Park - Fort Worth Construction Mortgage Loan is fully funded as of September 30, 2013.

See reporting definitions.
24
    

SABRA HEALTH CARE REIT, INC.
REPORTING DEFINITIONS


Acute Care Hospital. A facility designed to provide extended medical and rehabilitation care for patients who are clinically complex and have multiple acute or chronic conditions.
Adjusted EBITDA. The Company uses EBITDA (defined below), adjusted to exclude losses on extinguishment of debt and changes in fair value of contingent consideration ("Adjusted EBITDA"), a non-GAAP financial measure, as a measure of operating performance. By excluding interest expense and losses on extinguishment of debt, Adjusted EBITDA allows investors to measure the Company’s operating performance independent of its capital structure and indebtedness and, therefore, allows for a more meaningful comparison of its operating performance between quarters as well as annual periods and to compare its operating performance to that of other companies, both in the real estate industry and in other industries. The Company believes investors should consider Adjusted EBITDA in conjunction with net income attributable to common stockholders (the primary measure of the Company’s performance) and the other required GAAP measures of its performance, to improve their understanding of the Company’s operating results, and to make more meaningful comparisons of its performance between periods and against other companies. Adjusted EBITDA has limitations as an analytical tool and should be used in conjunction with the Company’s required GAAP presentations. Adjusted EBITDA does not reflect the Company’s historical cash expenditures or future cash requirements for capital expenditures or contractual commitments. Adjusted EBITDA does not represent net income, net income attributable to common stockholders or cash flow from operations as defined by GAAP and it should not be considered as an alternative to those indicators in evaluating operating performance or liquidity. Further, the Company’s computation of Adjusted EBITDA may not be comparable to similar measures reported by other companies.
Annualized Revenues. The annual straight-line rental revenues under leases. Annualized Revenues do not include tenant recoveries or additional rents.  The Company uses Annualized Revenues for the purpose of determining tenant concentrations and lease expirations.
EBITDA. The real estate industry uses earnings before interest, taxes, depreciation and amortization (“EBITDA”), a non-GAAP financial measure, as a measure of both operating performance and liquidity. The Company uses EBITDA to measure both its operating performance and liquidity. By excluding interest expense, EBITDA allows investors to measure the Company’s operating performance independent of its capital structure and indebtedness and, therefore, allows for a more meaningful comparison of its operating performance between quarters as well as annual periods and to compare its operating performance to that of other companies, both in the real estate industry and in other industries. As a liquidity measure, the Company believes that EBITDA helps investors analyze the Company’s ability to meet its interest payments on outstanding debt. The Company believes investors should consider EBITDA in conjunction with net income attributable to common stockholders (the primary measure of the Company’s performance) and the other required GAAP measures of its performance and liquidity, to improve their understanding of the Company’s operating results and liquidity, and to make more meaningful comparisons of its performance between periods and against other companies. EBITDA has limitations as an analytical tool and should be used in conjunction with the Company’s required GAAP presentations. EBITDA does not reflect the Company’s historical cash expenditures or future cash requirements for capital expenditures or contractual commitments. While EBITDA is a relevant and widely used measure of operating performance and liquidity, it does not represent net income, net income attributable to common stockholders or cash flow from operations as defined by GAAP and it should not be considered as an alternative to those indicators in evaluating operating performance or liquidity. Further, the Company’s computation of EBITDA may not be comparable to similar measures reported by other companies.
EBITDAR. Earnings before interest, taxes, depreciation, amortization and rent (“EBITDAR”) for a particular facility accruing to the operator/tenant of the property (not the Company) for the period presented. The Company uses EBITDAR in determining EBITDAR Coverage. EBITDAR has limitations as an analytical tool. EBITDAR does not reflect historical cash expenditures or future cash requirements for facility capital expenditures or contractual commitments. In addition, EBITDAR does not represent a property's net income or cash flow from operations and should not be considered an alternative to those indicators. The Company receives EBITDAR and other information from its operators/tenants and relevant guarantors and utilizes EBITDAR as a supplemental measure of their ability to generate sufficient liquidity to meet related obligations to the Company. All facility and tenant financial performance data is derived solely from information provided by operators/tenants and relevant guarantors without independent verification by the Company and is presented one quarter in arrears. The Company includes EBITDAR with respect to a property if the property was operated at any time during the period presented subject to a lease with the Company. EBITDAR for facilities with new tenants/operators are only included in periods subsequent to the Company's acquisition of the facilities. EBITDAR excludes the impact of strategic disposition candidates and facilities held for sale.
EBITDAR Coverage. EBITDAR for the trailing 3 and 12 month periods prior to and including the period presented divided by the same period cash rent for all of our facilities. EBITDAR Coverage is a supplemental measure of an operator/tenant's ability to meet their cash rent and other obligations to the Company. However, its usefulness is limited by, among other things, the same factors that limit the usefulness of EBITDAR. All facility and tenant data are derived solely from information provided by operators/tenants and relevant guarantors without independent verification by the Company and are only included for stabilized properties. All such data is presented one quarter in arrears and excludes the impact of strategic disposition candidates and facilities held for sale.
EBITDARM. Earnings before interest, taxes, depreciation, amortization, rent and management fees (“EBITDARM”) for a particular facility accruing to the operator/tenant of the property (not the Company), for the period presented. The Company uses EBITDARM in determining EBITDARM Coverage. The usefulness of EBITDARM is limited by the same factors that limit the usefulness of EBITDAR. Together with EBITDAR, the Company utilizes EBITDARM to evaluate the core operations of the properties by eliminating management fees, which vary based on operator/tenant and its operating structure. All facility financial performance data is derived solely from information provided by operators/tenants and relevant guarantors without independent verification by the Company. All such data is presented one quarter in arrears.

See reporting definitions.
25
    

SABRA HEALTH CARE REIT, INC.
REPORTING DEFINITIONS


The Company includes EBITDARM for a property if it was operated at any time during the period presented subject to a lease with the Company. EBITDARM for facilities with new tenants/operators are only included in periods subsequent to our acquisition of the facilities. EBITDARM excludes the impact of strategic disposition candidates and facilities held for sale.
EBITDARM Coverage. EBITDARM for the trailing 3 and 12 month periods prior to and including the period presented divided by the same period cash rent. EBITDARM coverage is a supplemental measure of a property's ability to generate cash flows for the operator/tenant (not the Company) to meet the operator's/tenant's related cash rent and other obligations to the Company. However, its usefulness is limited by, among other things, the same factors that limit the usefulness of EBITDARM. All facility and tenant data are derived solely from information provided by operators/tenants and relevant guarantors without independent verification by the Company and are only included for stabilized properties. All such data is presented one quarter in arrears and excludes the impact of strategic disposition candidates and facilities held for sale.
Enterprise Value. The Company believes Enterprise Value is an important measurement as it is a measure of a company’s value. We calculate Enterprise Value as market equity capitalization plus debt. Market equity capitalization is calculated as the number of shares of common stock multiplied by the closing price of our common stock on the last day of the period presented. Total Enterprise Value includes our market equity capitalization and consolidated debt, less cash and cash equivalents.
Fixed Charge Coverage. EBITDAR (including adjustments for one-time and pro forma items) for the period indicated (one quarter in arrears) for all operations of any entities that guarantee the tenants' lease obligations to the Company divided by the same period cash rent expense, interest expense and mandatory principal payments for operations of any entity that guarantees the tenants' lease obligation to the Company. Fixed Charge Coverage is a supplemental measure of a guarantor's ability to meet the operator/tenant's cash rent and other obligations to the Company should the operator/tenant be unable to do so itself. However, its usefulness is limited by, among other things, the same factors that limit the usefulness of EBITDAR. Fixed Charge Coverage is calculated by the Company as described above based on information provided by guarantors without independent verification by the Company and may differ from similar metrics calculated by the guarantors.
Funds From Operations (“FFO”) and Adjusted Funds from Operations (“AFFO”). The Company believes that net income attributable to common stockholders as defined by GAAP is the most appropriate earnings measure. The Company also believes that Funds From Operations, or FFO, as defined in accordance with the definition used by the National Association of Real Estate Investment Trusts (“NAREIT”), and Adjusted Funds from Operations, or AFFO (and related per share amounts) are important non-GAAP supplemental measures of operating performance for a real estate investment trust. Because the historical cost accounting convention used for real estate assets requires straight-line depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time. However, since real estate values have historically risen or fallen with market and other conditions, presentations of operating results for a real estate investment trust that uses historical cost accounting for depreciation could be less informative. Thus, NAREIT created FFO as a supplemental measure of operating performance for real estate investment trusts that excludes historical cost depreciation and amortization, among other items, from net income attributable to common stockholders, as defined by GAAP. FFO is defined as net income attributable to common stockholders, computed in accordance with GAAP, excluding gains or losses from real estate dispositions, plus real estate depreciation and amortization and impairment charges. AFFO is defined as FFO excluding non-cash revenues (including, but not limited to, straight-line rental income adjustments and non-cash interest income adjustments), non-cash expenses (including, but not limited to, stock-based compensation expense, amortization of deferred financing costs and amortization of debt discounts and premiums) and acquisition pursuit costs. The Company believes that the use of FFO and AFFO (and the related per share amounts), combined with the required GAAP presentations, improves the understanding of operating results of real estate investment trusts among investors and makes comparisons of operating results among such companies more meaningful. The Company considers FFO and AFFO to be useful measures for reviewing comparative operating and financial performance because, by excluding gains or losses from real estate dispositions, impairment charges and real estate depreciation and amortization, and, for AFFO, by excluding non-cash revenues (including, but not limited to, straight-line rental income adjustments and non-cash interest income adjustments), non-cash expenses (including, but not limited to, stock-based compensation expense, amortization of deferred financing costs and amortization of debt discounts and premiums) and acquisition pursuit costs, FFO and AFFO can help investors compare the operating performance of the Company between periods or as compared to other companies. While FFO and AFFO are relevant and widely used measures of operating performance of real estate investment trusts, they do not represent cash flows from operations or net income attributable to common stockholders as defined by GAAP and should not be considered an alternative to those measures in evaluating the Company’s liquidity or operating performance. FFO and AFFO also do not consider the costs associated with capital expenditures related to the Company’s real estate assets nor do they purport to be indicative of cash available to fund the Company’s future cash requirements. Further, the Company’s computation of FFO and AFFO may not be comparable to FFO and AFFO reported by other real estate investment trusts that do not define FFO in accordance with the current NAREIT definition or that interpret the current NAREIT definition or define AFFO differently than the Company.
Investment. Represents the carrying amount of real estate assets after adding back accumulated depreciation and amortization.
Licensed Beds/Units. Senior housing facilities are measured in units (e.g., studio, one or two bedroom units). Skilled nursing and mental health facilities are measured in licensed bed count. All facility financial performance data were derived solely from information provided by operators/tenants without independent verification by the Company.
Market Capitalization. Total common shares of Sabra outstanding multiplied by the closing price per common share as of a given period.

See reporting definitions.
26
    

SABRA HEALTH CARE REIT, INC.
REPORTING DEFINITIONS


Normalized FFO and AFFO. Normalized FFO represents FFO adjusted for non-recurring income and expenses. Normalized AFFO represents AFFO adjusted for one-time start-up costs and non-recurring income and expenses. The Company considers normalized FFO and AFFO to be a useful measure to evaluate the Company’s operating results excluding start-up costs and non-recurring income and expenses. Normalized FFO and AFFO can help investors compare the operating performance of the Company between periods or as compared to other companies. Normalized FFO and AFFO do not represent cash flows from operations or net income as defined by GAAP and should not be considered an alternative to those measures in evaluating the Company’s liquidity or operating performance. Normalized FFO and AFFO also do not consider the costs associated with capital expenditures related to the Company’s real estate assets nor does it purport to be indicative of cash available to fund the Company’s future cash requirements. Further, the Company’s computation of normalized FFO and AFFO may not be comparable to normalized FFO and AFFO reported by other REITs that do not define FFO in accordance with the current NAREIT definition or that interpret the current NAREIT definition or define FFO and AFFO or normalized FFO and normalized AFFO differently from the Company.
Occupancy Percentage. Occupancy Percentage represents the facilities’ average operating occupancy for the period indicated. The percentages are calculated by dividing the actual census from the period presented by the available beds/units for the same period. Occupancy for independent living facilities can be greater than 100% for a given period as multiple residents could occupy a single unit. All facility financial performance data were derived solely from information provided by operators/tenants without independent verification by the Company and are only included for stabilized properties. All facility financial performance data are presented one quarter in arrears. The Company includes the occupancy percentage for a property if it was owned by the Company at any time during the period presented and excludes the impact of strategic disposition candidates and facilities held for sale. Occupancy Percentage for facilities with new tenants/operators are only included in periods subsequent to our acquisition of the facilities.
Senior Housing. Senior housing facilities include independent living, assisted living, continuing care retirement community and memory care facilities.
Skilled Mix. Skilled Mix is defined as the total Medicare and non-Medicaid managed care patient revenue at skilled nursing facilities divided by the total revenues at skilled nursing facilities for any given period. All facility financial performance data were derived solely from information provided by the Company's tenants without independent verification by the Company and are only included for stabilized properties. All facility financial performance data are presented one quarter in arrears. The Company includes skilled mix for a property if it was owned by the Company at any time during the period presented and excludes the impact of strategic disposition candidates and facilities held for sale. Skilled Mix for facilities with new tenants/operators are only included in periods subsequent to our acquisition of the facilities.
Skilled Nursing/Post-Acute. Skilled nursing/post-acute facilities include skilled nursing facilities, multi-license designation, and mental health facilities.
Total Debt. The carrying amount of the Company’s secured revolving credit facility, senior unsecured notes, and mortgage indebtedness, as reported in the Company’s consolidated financial statements.
Total Secured Debt. Mortgage and other debt secured by real estate.



See reporting definitions.
27